First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine
bioRxiv (2020) - Comments
doi: 10.1101/2020.08.05.20168435 

Cheryl Keech, Gary Albert, Patricia Reed, Susan Neal, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Haixia Zhou, Nita Patel, Matthew B. Frieman, Robert E. Haupt, James Logue, Marisa McGrath, Stuart Weston, Pedro A. Piedra, Iksung Cho, Andreana Robertson, Chinar Desai, Kathleen Callahan, Maggie Lewis